Acelrx pharmaceuticals announces publication of clinical data on decreased postoperative opioid requirements and enhanced postanesthesia recovery following perioperative use of dsuvia®

Redwood city, calif., dec. 10, 2020 /prnewswire/ -- acelrx pharmaceuticals, inc. (nasdaq: acrx), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings, today announced the publication by the...
ACRX Ratings Summary
ACRX Quant Ranking